Charles Schoch
Senior VP, CFO, Treasurer & SecretaryMr. Charles Schoch serves as the Chief Financial Officer of Candel Therapeutics, Inc. from June 23, 2025 and served as its Interim Chief Financial Officer from January 12, 2024 to June 14, 2025 and has been its Treasurer and Secretary and serves as its Senior VP since January 2025 and served as its Vice President of Finance and Corporate Controller since March 2023 until January 2024. He was Principal Accounting Officer at Candel Therapeutics, Inc. until June 23, 2025. Mr. Schoch joined the Candel Therapeutics, Inc. in November 2021 and has served in various financial reporting and accounting positions of increasing responsibility. Prior to joining the Candel Therapeutics, Mr. Schoch was the Corporate Controller at Corbus Pharmaceuticals from September 2020 to November 2021 and previously worked in the Health Industry assurance practice of PricewaterhouseCoopers from September 2013 to August 2020. Mr. Schoch holds an M.B.A. and M.S.A. from Northeastern University and a B.S. in Business Administration with a concentration in Finance from Elon University. Mr. Schoch is a Certified Public Accountant in the Commonwealth of Massachusetts.
Positions
- Company NameCandel Therapeutics, Inc.Stock CodeCADLPositionSenior VP, CFO, Treasurer & SecretaryColleagues
- PTPaul-Peter TakPresident, CEO & Director
- PBPaul B. ManningIndependent Chairman
- FBFrancesca BaroneChief Scientific Officer
- STSeshu TyagarajanChief Technical & Development Officer
- TJTheodore JenkinsVice President of Investor Relations & Business Development
- EJEdward John BenzMember of Research Advisory Board & Independent Director
- RMRenee M. GaetaIndependent Director
- NLNicoletta LoggiaIndependent Director
